Lv65
1610 积分 2023-02-08 加入
Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors
17小时前
已完结
CD19 chimeric antigen receptor (CAR) engineered epstein-barr virus (EBV) specific T cells – an off-the-shelf, allogeneic CAR T-cell immunotherapy platform
14天前
已完结
GPCR drug discovery: new agents, targets and indications
23天前
已完结
Fibrosis: cross-organ biology and pathways to development of innovative drugs
23天前
已完结
RNA chemistry and therapeutics
23天前
已完结
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
24天前
已完结
Establishment of EBV-Infected Lymphoblastoid Cell Lines
28天前
已完结
Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders
29天前
已完结
GMP production and testing of Xcellerated T Cells™ for the treatment of patients with CLL
29天前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
1个月前
已完结
皖公网安备34019202002308
